# Denali Therapeutics Inc.: Form DEF 14A, filed Apr 19, 2022

- Company: [Denali Therapeutics Inc.](/companies/dnli.md) (CIK 1714899)
- Form: DEF 14A
- Filed: 2022-04-19
- Accepted by EDGAR: Apr 19, 2022, 16:02 ET
- Period: 2022-06-02
- Accession: 0001714899-22-000068
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1714899/000171489922000068/a2022fy21def14aproxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1714899/000171489922000068/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1714899/000171489922000068/a2022fy21def14aproxy.htm

Filed Apr 19, 2022.
Source: SEC EDGAR, the filing index for accession 0001714899-22-000068. Last ingested by Listed: Nov 3, 2026, 19:01 ET. No prices; not investment advice.
